Industries We Serve
Orthopedic & Spinal Implant Regulatory & Quality
Regulatory and quality support for joints, plates, screws, and spinal hardware that has to live inside the body.
Overview
Orthopedic and spinal implants — total joints, bone plates, screws, intramedullary nails, interbody cages, and spinal fixation systems — are permanent, load-bearing, long-term-contact devices, and FDA reviews them that way. Most clear through the 510(k) pathway against well-established predicates and recognized consensus standards, while novel materials, geometries, or indications can push a device into De Novo or PMA territory. What makes this vertical distinct is the weight FDA places on mechanical evidence: static and dynamic fatigue performance under recognized ASTM and ISO methods, paired with implant-grade biocompatibility and a sterilization and packaging story that survives shelf life. We handle the regulatory and quality side of all of it so your engineers can stay on the device.
FDA Pathway & Classification
The large majority of orthopedic and spinal implants are Class II and reach market via the Traditional 510(k), where strong predicate selection against legally marketed plates, screws, joints, or fixation systems is the foundation of the submission. FDA-recognized special controls and consensus standards (the ASTM F-series for mechanical testing, ISO 10993 for biocompatibility) make these reviews highly evidence-driven, and many product codes carry specific guidance documents we map against early. Devices with novel mechanisms, materials, or expanded indications — certain motion-preserving spinal devices and some total joint constructs — can fall under Class III PMA, while genuinely new low-to-moderate-risk types without a predicate are candidates for De Novo. For the EU, these implants are typically Class IIb or Class III under MDR, requiring Notified Body review, clinical evaluation, and PMCF — a materially higher bar than the prior MDD, and one worth scoping before you commit to a CE pathway.
Quality & Risk
Orthopedic implants demand a mature ISO 13485 quality system and a clean design history file, because the DHF is exactly what FDA and Notified Bodies pull apart during review and audit. Design controls have to trace user needs and intended use through design inputs, mechanical and biocompatibility verification, and design validation, with every test protocol and report linked back to a requirement. ISO 14971 risk management is central — fatigue failure, fretting and wear debris, particulate, corrosion, loosening, and revision-surgery consequences all belong in the risk file with documented controls and benefit-risk justification. Because these are long-term implanted, tissue- and bone-contacting devices, biocompatibility follows the ISO 10993-1 framework for permanent implant contact (cytotoxicity, sensitization, irritation, systemic toxicity, genotoxicity, implantation, and chemical characterization, with material-mediated considerations for metals, PEEK, and coatings). Sterilization validation to ISO 11135 (EO) or ISO 11137 (radiation), package integrity and shelf life to ISO 11607, and disciplined CAPA close the loop from design through production.
In-Family Testing
This is where being part of the Boulder BioMedical family does real work. Boulder BioLabs coordinates the ISO 10993 program that implants live and die on — cytotoxicity, sensitization, irritation, and the microbiological and residuals testing that ties back to sterilization. Boulder Sterilization runs EO validation to ISO 11135 (and chlorine dioxide where it fits), so the sterility claim in your submission is backed by real cycle development, not a borrowed master file. Boulder Package Testing validates the sterile barrier and shelf life to ISO 11607 with accelerated and real-time aging, distribution simulation, and seal integrity — the package data FDA expects alongside the device. And Boulder iQ brings the engineering and manufacturing depth to design test fixtures, support mechanical and fatigue protocols to the ASTM F-series, and transfer the design to production. We assemble the evidence; we don’t just file paperwork around someone else’s.
We Live It, Not Just Advise It
We run an FDA-registered operation, and the implant evidence we cite is the kind we generate and stand behind every day across the Boulder family. We’ve sat on both sides of the audit table and built the design history files we now help clients defend. That’s the difference between a consultant who describes the requirement and a partner who has already met it.
Frequently Asked Questions
My implant is similar to several cleared devices. Is the 510(k) just a paperwork exercise?
Rarely. For orthopedic and spinal implants, FDA expects the substantial equivalence argument to be backed by mechanical performance data — static and dynamic fatigue testing under the relevant ASTM F-series methods — even when a strong predicate exists. The predicate establishes intended use and technological characteristics; the bench testing proves your device performs as well or better. We build the predicate strategy and the test plan together so the submission tells one coherent story rather than a comparison table waiting for an Additional Information request.
What biocompatibility testing does a permanent orthopedic implant actually need?
Implants are evaluated under ISO 10993-1 as permanent, tissue- and bone-contacting devices, which is the most demanding contact category. That typically drives cytotoxicity, sensitization, irritation or intracutaneous reactivity, acute and subchronic systemic toxicity, genotoxicity, implantation, and increasingly a chemical characterization and toxicological risk assessment for the specific alloy, PEEK, or coating. The right approach starts with a biological evaluation plan that justifies which endpoints apply based on materials and processing — leveraging existing data where defensible — so you test what FDA needs and not a generic checklist. Boulder BioLabs runs the program in family.
How early should I think about sterilization and packaging for an implant program?
Earlier than most teams do. Sterilization method, EO or radiation, affects materials, residuals, and your biocompatibility plan, and the sterile barrier and shelf-life claims under ISO 11607 require accelerated and real-time aging that takes calendar time you can’t compress at the end. We fold sterilization validation and package integrity into the design-control timeline from the start, with Boulder Sterilization and Boulder Package Testing generating the validation and aging data, so it’s ready when the submission is rather than becoming the thing that holds up your filing.
Ready to Talk Through Your Orthopedic Implants Program?
Tell us where you are in the process. We respond within one business day.
Request a ConsultThe Boulder BioMed Family
One campus, one quality system. We manufacture, sterilize, and test medical devices in-house — so our regulatory and quality work is grounded in operations, not theory.